Project Grant R01AI198780
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $127,926 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. The grant supports research to characterize autoreactive B cells and their roles in the pathogenesis of systemic lupus erythematosus (SLE) using immune organoids. The funded research will deliver scientific...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $3,045,291 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025 through July 31, 2029. This collaborative research initiative, led by the Carette, Chiu, and Nagamine laboratories, will investigate the molecular mechanisms by which the MFSD6 (Major Facilitator Superfamily Domain-containing 6)...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $237,476 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025 through July 31, 2027. This award funds fundamental research investigating the role of Epstein-Barr virus (EBV) in multiple sclerosis (MS) pathogenesis. The research aims to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant totaling $246,881 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 13, 2026, with a completion date of January 31, 2028. The grant funds advanced structural research on varicella-zoster virus (VZV) glycoprotein complexes using cryo-electron microscopy (cryo-EM) techniques. The primary deliverables include...
- Federal Project Grant Award Summary The University of Iowa received a $427,627 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025, through June 30, 2027. This award funds biomedical research investigating the role of gamma herpesvirus—specifically Epstein-Barr virus (EBV)—in triggering or augmenting myelin autoimmunity relevant to multiple sclerosis (MS) etiology....
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $809,250 Project Grant on April 8, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to advance induced pluripotent stem cell (iPSC)-derived thymic epithelial cell (TEC) therapy for T cell immune reconstitution in vulnerable populations. The research, conducted in Palo Alto, California through March 31, 2031, focuses on...
- The U.S. Defense Health Agency awarded a $250,000 Project Grant on July 1, 2023 to The Leland Stanford Junior University, also known as Stanford University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports the isolation and engineering of potent anti-EBV neutralizing antibodies for the treatment of multiple sclerosis (MS). The project will be conducted at Stanford University's campus in Stanford, California over a 2-year period, ending on June 30,...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $151,040 Project Grant effective February 25, 2026, through September 17, 2028, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports investigator-initiated research examining the impact of nuclear envelope protein degradation on neutrophil lipid content and migration. The project develops and applies a nanobody-based...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant totaling $150,104.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on March 10, 2026, with an anticipated completion date of October 31, 2028. The award supports research aimed at developing a spillover risk model for Japanese Encephalitis Virus (JEV) in the United States. This research addresses a critical gap in...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $771,210 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct basic biomedical research on Salmonella persistence mechanisms in mammalian host tissues. The research project, initiated February 19, 2026, and scheduled for completion January 31, 2031, will be performed at Stanford's Palo Alto, California...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $778,827 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to characterize Epstein-Barr Virus (EBV)-infected B cells in patients with multiple sclerosis (MS). The award, effective May 8, 2026, through April 30, 2031, supports research utilizing an innovative technology pipeline called ELUCIDATE (EBER-labeled Unique Cell Identification and Deep Analysis of Transcriptomes, Immune Repertoires, and EBV-genes). This method enables isolation and characterization of latently EBV-infected B cells through flow cytometry and single-cell sequencing to analyze their transcriptomes, immune repertoires, viral genes, and small non-coding RNAs. The research addresses a critical knowledge gap regarding the relationship between EBV infection and MS pathogenesis, given that nearly 100% of MS patients contract EBV prior to disease onset. The project will identify specific characteristics of EBV-positive B cells in MS patients compared to those with systemic lupus erythematosus (SLE) and healthy individuals, investigating how viral dysregulation of B cells contributes to autoimmunity and disease development. Work will be conducted at Stanford's Palo Alto, California location.Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $778.8k | 5/12/26 |